Back to Search Start Over

Sixteen-Year Follow-Up in a Cavernous Sinus Hemangiopericytoma: Improved Outcomes over Radiotherapy Advances.

Authors :
Detti B
Bardoscia L
Pisani AR
Cozzi S
Roghi M
Mammucci P
Sardaro A
Source :
Brain sciences [Brain Sci] 2022 Sep 08; Vol. 12 (9). Date of Electronic Publication: 2022 Sep 08.
Publication Year :
2022

Abstract

Intracranial hemangiopericytomas are rare tumors, accounting for 1% of all central nervous system malignancies. This tumor is considered at high risk of local and also distant metastases. Surgical excision is the gold standard for treatment, but it is seldom curative by itself. Adjuvant radiotherapy is often recommended. We report an overview and update of the available literature on one such rare but aggressive mesenchymal tumor, using the case of a 46-year-old woman affected by hemangiopericytoma of the cavernous sinus surgically removed and treated with adjuvant radiotherapy at our institution. After seven years, the patient underwent a local recurrence and was treated with exeresis and Gamma Knife radiotherapy. Sixteen years after the initial diagnosis, she is still well with stable disease.

Details

Language :
English
ISSN :
2076-3425
Volume :
12
Issue :
9
Database :
MEDLINE
Journal :
Brain sciences
Publication Type :
Report
Accession number :
36138945
Full Text :
https://doi.org/10.3390/brainsci12091209